SGLT2 inhibitors
Controversies in New Diabetes Therapies
The launch of concentrated insulins and sodium–glucose cotransporter-2 inhibitors has been a boon for some ...
JULY 13, 2017
New Class of Diabetes Drugs Raises Safety Questions
Serious concerns about safety and efficacy emerge after more than 2 million perscriptions written.
JULY 2, 2016
Load more